Business
PrimaryBid.com Offers
PrimaryBid.com Offers.
About this update from Avacta Group Plc
[{"type":"text","content":"\n \n \n RNS Number : 9455O\n Avacta Group PLC\n 04 June 2020\n \n \n \n \n \n \n \n \n THIS ANNOUNCEMENT, AND THE INFORMATION CONTAINED HEREIN, IS NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO OR FROM THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO.\n \n \n \n THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY, AND DOES NOT CONSTITUTE OR FORM PART OF ANY OFFER OR INVITATION TO SELL OR ISSUE, OR ANY SOLICITATION OF AN OFFER TO PURCHASE OR SUBSCRIBE FOR, ANY SECURITIES OF\n \n \n \n AVACTA GROUP PLC.\n \n \n \n THE INFORMATION COMMUNICATED WITHIN THIS ANNOUNCEMENT IS DEEMED TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014. UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.\n \n \n THIS ANNOUNCEMENT AMOUNTS TO A FINANCIAL PROMOTION FOR THE PURPOSES OF SECTION 21 OF THE FINANCIAL SERVICES AND MARKETS ACT 2000 (\"FSMA\") AND HAS BEEN APPROVED BY PRIMARYBID LIMITED WHICH IS AUTHORISED AND REGULATED BY THE FINANCIAL CONDUCT AUTHORITY (FRN 779021).\n \n \n 4 June 2020\n \n \n Avacta Group plc\n \n \n (\"Avacta\" or the \"\n \n Company\n \n \")\n \n \n PrimaryBid.com Offers\n \n \n 1. Introduction\n \n \n Avacta Group plc (AIM: AVCT)\n , the developer of Affimer® biotherapeutics and reagents, announces offers for subscription via PrimaryBid \n of new ordinary shares of 10p each in the Company (\"New Ordinary Shares\") at an issue price of \n 120\n pence per New Ordinary Share (the \"Issue Price\"), being a discount of \n 4.4\n \n per cent to the \n \n 30\n \n day volume weighted average price of the Company's ordinary shares on the AIM market of London Stock Exchange plc (\"AIM\n \n \"\n ) on \n 3\n \n June 2020, being \n \n 125.3\n \n pence per Ordinary Share.\n \n \n \n The Company is also conducting a non-pre-emptive placing of new Ordinary Shares at the Issue Price (the \"Placing Shares\") by way of an accelerated bookbuild process being carried out by finnCap Ltd (acting as nominated adviser), and finnCap Ltd, Zeus Capital Limited and Beech Hill Securities, Inc. acting as joint brokers \n (together, the \"Joint Brokers\"...